- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
Professor Dean A. Fennell FRCP PhD FRSB is a world leading expert in the research and treatment of patients with malignant mesothelioma. He is currently director of the Leicester Mesothelioma Research Programme.
He initially qualified with a first class degree in Pharmacology followed by Medicine and Surgery from University College London. After basic specialist training at UCL, Hammersmith, Brompton, Guy’s and St Thomas’ Hospitals in London he obtained Membership of the Royal College of Physicians, followed by a PhD in Oncology as a MRC Clinical research fellow in UCL. He completed training in Medical Oncology at St Bartholomew’s Hospital, and then undertook back-to-back Cancer Research UK Clinician Scientist Fellowships, until his current appointment in 2012.
He was elected fellow of the Royal College of Physicians (London) in 2007 and served two terms on the board of the EORTC based in Brussels. He is a member of the IASLC & European mesothelioma taskforce, past IMIG president/NCRI mesothelioma CSG chair. Prof. Fennell has 170 publications in the highest impact journals including New England Journal of Medicine, Nature, Lancet, Lancet Oncology.
Areas of interest
Mesothelioma, genetic profiling, targeted therapy, immunotherapy, clinical trials
Medical secretaries
- Sarah Pascale
- Oncology Department, Osborne Building Leicester Royal Infirmary NHS Trust Infirmary Square Leicester LE1 5WW
- +441162587632
- sarah.pascale@uhl-tr.nhs.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)